Little Green Pharma Ltd. is a pharmaceutical company specializing in the cultivation, production, and distribution of medicinal cannabis products. Founded in 2016 and based in West Perth, Australia, the company operates as a vertically integrated global business, managing the supply chain from raw material procurement through to manufacturing and international distribution. Its core offerings include pharmaceutical-grade dried cannabis flowers and cannabis oils, manufactured in environmentally controlled facilities that emphasize pesticide-free hydroponic cultivation methods. Little Green Pharma services both domestic and international markets, with a particularly strong presence in Australia and expanding operations across Europe. Beyond supplying medicinal cannabis for patient consumption and clinical studies, the company engages in research and development, including initiatives in psychedelic medicine such as psilocybin-assisted therapy trials for refractory depression. Little Green Pharma plays a significant role in the healthcare and specialty drug sectors, offering both its own branded and white-label products and supporting innovation in alternative medicine. Its ongoing expansion in research and product range underscores its position as a key contributor to medicinal cannabis access and development within the global pharmaceutical industry.